查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球乳房活體組織切片設備市場：按類型、按程序、按技術、按用途、按最終用戶、按地區 - 預測到2028年
市場調查報告書
商品編碼
1342071

全球乳房活體組織切片設備市場：按類型、按程序、按技術、按用途、按最終用戶、按地區 - 預測到2028年

Breast Biopsy Devices Market by Type, Procedure, Technique, Application, End User & Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 260 Pages | 訂單完成後即時交付

價格
簡介目錄

全球乳房活體組織切片設備市場規模預計將從2023年的16億美元增至2028年的26億美元，2023年至2028年的年複合成長率為10.0%。

市場成長受到多種要素的推動，例如乳房癌患病率的增加、乳房癌篩查計劃的增加、有利的償付設置、乳房癌早期檢測意識的提高以及對微創和無創手術的需求不斷增加。這些要素是市場擴張的關鍵促進因素，為行業創造了巨大的商機。

乳房活體組織切片設備市場按類型分為活體組織切片針、引導系統、活體組織切片台、定位線、檢測套件、液態生物檢體設備和其他設備。活體組織切片針細分市場佔據主要佔有率。該細分市場佔據顯著市場主導地位的主要原因是新興市場中乳房癌發病率的增加和乳房癌診斷率的上升。此外，政府的支持措施，例如建立乳房癌篩查計劃和宣傳活動，預計將進一步促進乳房活體組織切片的採用。

乳房活體組織切片設備市場按用途大致分為早期癌症篩查、治療選擇、治療監測和復發監測。該行業的顯著成長歸因於有利的償付方案和先進醫療基礎設施的可用性。過去幾十年來，基於腫瘤組織遺傳分析的精準醫學和個體化治療的出現，預計將帶來更特異性的治療選擇，並在預測期內進一步影響該領域的成長。

按手術方式，乳房活體組織切片市場大致分為針吸乳房活體組織切片、開放性手術乳房活體組織切片和液體乳房活體組織切片。回顧期內該細分市場的顯著成長歸因於新產品的批准和推出。從事液體乳房活體組織切片市場的公司透過資金和贈款積極投資於臨床試驗和研究，這推動市場的進一步擴張。行業參與者的這些努力預計將推動液體乳房活體組織切片領域的成長。

預計北美地區的乳房活體組織切片設備市場將在預測期內佔據重要佔有率，這主要是由於該地區醫療保健支出較高和目標疾病患病率上升。此外，技術的不斷進步、乳房癌罹患率的增加、有利的償付條款以及美國新乳房密度通知法的實施預計將進一步推動市場成長。

本報告研究了全球乳房活體組織切片設備市場，包括按類型、程序、技術、用途、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

第1章 簡介

第2章 調查方法

第3章 執行摘要

第4章 重要考察

第5章 市場概況

  • 介紹
  • 市場動態
  • 法規狀況
  • 價值鏈分析
  • 供應鏈分析
  • 生態系統市場地圖
  • 技術分析
  • 貿易分析
  • 專利分析
  • 波特五力分析
  • 價格分析
  • 案例研究分析
  • 2023-2025年重大會議和活動
  • 主要相關人員和採購標準

第6章 乳房活體組織切片設備市場，按類型

  • 介紹
  • 活體組織切片針
  • 引導系統
  • 活體組織切片台
  • 檢測試劑盒
  • 液態生物檢體儀器
  • 定位線
  • 其他

第7章 乳房活體組織切片設備市場，按程序

  • 介紹
  • 乳房穿刺活體組織切片
  • 開放手術乳房活體組織切片
  • 乳房液體活體組織切片

第8章 乳房活體組織切片設備市場，按技術

  • 介紹
  • 影像引導生檢
  • 液態生檢
  • 其他

第9章 乳房活體組織切片設備市場，按用途

  • 介紹
  • 早期癌症篩查
  • 治療選擇
  • 治療監測
  • 復發監測

第10章 乳房活體組織切片設備市場，按最終用戶

  • 介紹
  • 醫院和外科中心
  • 乳房護理中心
  • 影像診所和診斷中心

第11章 乳房活體組織切片設備市場，按地區

  • 介紹
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲

第12章 競爭形勢

  • 介紹
  • 主要參與企業採取的策略
  • 收入佔有率分析
  • 市場佔有率分析
  • 主要企業企業評價矩陣（2022年）
  • 初創企業/中小企業的企業評估矩陣（2022）
  • 競爭標杆管理
  • 公司足跡分析
  • 競爭場景

第13章 公司簡介

  • 主要參與企業
    • HOLOGIC, INC.
    • DANAHER CORPORATION
    • BECTON, DICKINSON AND COMPANY
    • QIAGEN
    • F. HOFFMANN-LA ROCHE LTD.
    • ARGON MEDICAL DEVICES
    • MERIT MEDICAL SYSTEMS
    • MENARINI SILICON BIOSYSTEMS SPA
    • GUARDANT HEALTH, INC.
    • NEOGENOMICS LABORATORIES, INC.
    • STERYLAB SRL
    • BIOCEPT, INC.
    • BIO-RAD LABORATORIES, INC.
    • EXACT SCIENCES CORPORATION
    • SYSMEX INOSTICS, INC.（A SUBSIDIARY OF SYSMEX CORPORATION）
  • 其他公司
    • THERMO FISHER SCIENTIFIC
    • CARDIFF ONCOLOGY INC.
    • MYRIAD GENETICS, INC.
    • ILLUMINA, INC.
    • FLUXION BIOSCIENCES, INC.
    • FUJIFILM HOLDINGS CORPORATION
    • INRAD, INC.
    • IZI MEDICAL PRODUCTS
    • REMINGTON MEDICAL INC.
    • CP MEDICAL

第14章 附錄

簡介目錄
Product Code: MD 3615

The global breast biopsy devices market is projected to reach USD 2.6 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 10.0% from 2023 to 2028. The market growth is propelled by various factors, including the growing prevalence of breast cancer, the increasing implementation of breast cancer screening programs, favorable reimbursement settings, heightened awareness of early breast cancer detection, and rising demand for minimally invasive and non-invasive procedures. These factors are key drivers of market expansion, presenting significant business opportunities in the industry.

"The biopsy needles sub-segment to hold the largest share of the market in 2023."

Based on type, the breast biopsy devices market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other devices. The biopsy needles sub-segment held a major share of the market. The advantages offered by the substantial market dominance of this segment can be primarily attributed to the increasing occurrence of breast cancer and the rising rate of breast cancer diagnosis in emerging markets. Moreover, supportive government initiatives, such as the establishment of breast cancer screening programs and awareness campaigns, are anticipated to drive the adoption of breast biopsy procedures further.

"The therapy selection application segment is projected to register the highest growth during the forecast period."

Based on application, the near breast biopsy market is broadly categorized into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring. The significant growth of the segment is attributed to the favorable reimbursement scenario and availability of advanced healthcare infrastructure. The emergence of precision medicine and personalized cancer treatment based on genetic analysis of tumor tissue over the past few decades has resulted in more specific treatment options which is further expected to influence the growth of the segment during the forecast period.

"The liquid breast biopsy segment is projected to register the highest CAGR during the forecast period."

Based on procedure, the breast biopsy market is broadly categorized into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. The substantial growth of this segment during the review period can be attributed to the approvals and launches of new products. Companies operating in the liquid breast biopsy market are actively investing in clinical trials and research through funding and grants, which will fuel further market expansion. These initiatives by industry players are expected to drive the growth of the liquid breast biopsy segment.

"The market in the North America region is expected to witness the highest growth during the forecast period."

The breast biopsy market in the North America region is expected to hold a major share during the forecast period, primarily due to the high healthcare spending in the region and the rising prevalence of target diseases. Moreover, continuous advancements in technology, increasing incidence rates of breast cancer, favorable reimbursement conditions, and the implementation of new breast density notification laws in the US will further boost market growth.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
  • By Designation: C-level-10%, Director-level-14%, and Others-76%
  • By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, and the Middle East & Africa-3%

The prominent players in the breast biopsy devices market include Hologic Inc. (US), Danaher Corporation (US), Argon Medical Devices (US), Merit Medical Systems (US), Menarini-Silicon Biosystems (ITL), Becton Dickinson, and Company (US), Sterylab S.R.L ( Italy), Biocept, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Guardant Health, Inc. (US), NeoGenomics (US), Sysmex Inostics (Germany), Qiagen (Germany), Exact Sciences Corporation (US).

Research Coverage

This report studies the breast biopsy market based on type, procedure, technique, application, end-user, and geography. This study analyses the breast biopsy market. Additionally, it discusses the elements that influence market expansion, examines the opportunities and difficulties that exist in the sector, and gives information on the market's competitive environment for market leaders. The research also examines the growth trends of micro-markets and projects the revenue of market segments for each of the five major regions (as well as the individual nations within each region).

Reasons to Buy the Report

The market leaders and new entrants will benefit from the report's information on the revenue figures that are most closely approximated for the entire breast biopsy market and its subsegments. This study will assist stakeholders in comprehending the competitive environment and gaining deeper insights to better position their companies and develop appropriate go-to-market strategies. In addition, the research provides details on the major market drivers, constraints, challenges, and opportunities, assisting stakeholders in understanding the industry's pulse.

This report provides insights on the following pointers:

  • Analysis of key drivers (increasing incidence of breast cancer, increasing number of breast cancer screening programs, increasing demand for minimally invasive and non-invasive procedures, growing awareness regarding early detection of breast cancer, improved reimbursement scenario), restraints (risk of infections associated with the use of biopsy needles, stringent regulatory approval procedures product recalls), opportunities (emerging economies offer high growth potential, the emergence of liquid biopsy and promising clinical trials, increasing public-private investments and funding) and challenges (underdeveloped healthcare infrastructure and dearth of resources in developing countries).
  • Product development/innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the breast biopsy market.
  • Market development: comprehensive information about lucrative markets-the report analyses the breast biopsy market across varied regions.
  • Market diversification: exhaustive information about new products, untapped geographies, recent developments, and investments in the breast biopsy market.
  • Competitive assessment: in-depth assessment of market shares, growth strategies, and service offerings of leading players like Hologic Inc. (US), Becton Dickinson, and Company (US), Danaher Corporation (US), Argon Medical Devices(US), Merit Medical Systems (US), Menarini-Silicon Biosystems (ITL), Guardant Health, Inc. (US), NeoGenomics (US), Sysmex Inostics (Germany), Sterylab S.R.L ( Italy), Qiagen (Germany), and Biocept, Inc. (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES
    • 1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 GLOBAL BREAST BIOPSY DEVICES MARKET: RESEARCH METHODOLOGY STEPS
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 BREAST BIOPSY DEVICES MARKET: BREAKDOWN OF PRIMARIES
      • 2.1.2.1 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.2.2 END-USER-BASED MARKET SIZE ESTIMATION
    • FIGURE 6 BREAST BIOPSY DEVICES MARKET: END-USER-BASED ESTIMATION
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH LIMITATIONS
  • 2.5 RISK ASSESSMENT
    • TABLE 1 BREAST BIOPSY DEVICES MARKET: RISK ASSESSMENT ANALYSIS
  • 2.6 BREAST BIOPSY DEVICES MARKET: RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 8 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 9 BREAST BIOPSY DEVICES MARKET SHARE, BY PROCEDURE, 2023 VS. 2028
    • FIGURE 10 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 BREAST BIOPSY DEVICES MARKET SHARE, BY APPLICATION, 2023 VS. 2028
    • FIGURE 12 BREAST BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF BREAST BIOPSY DEVICES MARKET

4 PREMIUM INSIGHTS

  • 4.1 BREAST BIOPSY DEVICES MARKET OVERVIEW
    • FIGURE 14 INCREASING PREVALENCE OF BREAST CANCER TO DRIVE MARKET GROWTH
  • 4.2 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 ASSAY KITS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.3 BREAST BIOPSY DEVICES MARKET, PROCEDURE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 NEEDLE BREAST BIOPSY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.4 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 17 IMAGE-GUIDED BIOPSY TO ACCOUNT FOR LARGEST SHARE OF BREAST BIOPSY DEVICES MARKET IN 2028
  • 4.5 BREAST BIOPSY DEVICES MARKET, APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 18 EARLY CANCER SCREENING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.6 BREAST BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 19 BREAST CARE CENTERS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.7 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021-2028
    • FIGURE 20 ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 BREAST BIOPSY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing incidence of breast cancer
    • FIGURE 22 NUMBER OF BREAST CANCER CASES, BY COUNTRY, 2020
      • 5.2.1.2 Increasing number of breast cancer screening programs
      • 5.2.1.3 Increasing demand for minimally invasive and non-invasive procedures
      • 5.2.1.4 Growing awareness of early detection of breast cancer
      • 5.2.1.5 Improved reimbursement scenario
    • TABLE 2 MEDICARE REIMBURSEMENT FOR BREAST BIOPSY PROCEDURES
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Risk of infections associated with biopsy needles
      • 5.2.2.2 Stringent regulatory approval procedures
      • 5.2.2.3 Product recalls
    • TABLE 3 FDA-INITIATED PRODUCT RECALLS
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth potential in emerging economies
      • 5.2.3.2 Emergence of liquid biopsy and promising clinical trials
    • TABLE 4 LIQUID BIOPSY CLINICAL TRIALS
      • 5.2.3.3 Increasing public-private investments and funding
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled professionals and inadequate healthcare infrastructure
  • 5.3 REGULATORY LANDSCAPE
    • 5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.3.2 REGULATORY ANALYSIS
      • 5.3.2.1 North America
        • 5.3.2.1.1 US
    • TABLE 10 US FDA-APPROVED BIOPSY DEVICES
    • TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
        • 5.3.2.1.2 Canada
    • TABLE 13 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.3.2.2 Europe
      • 5.3.2.3 Asia Pacific
        • 5.3.2.3.1 Japan
    • TABLE 14 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
        • 5.3.2.3.2 China
    • TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
        • 5.3.2.3.3 India
  • 5.4 VALUE CHAIN ANALYSIS
    • 5.4.1 RESEARCH & DEVELOPMENT
    • 5.4.2 PROCUREMENT & PRODUCT DEVELOPMENT
    • 5.4.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES
    • FIGURE 23 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
  • 5.5 SUPPLY CHAIN ANALYSIS
    • 5.5.1 PROMINENT COMPANIES
    • 5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
    • 5.5.3 END USERS
    • FIGURE 24 BREAST BIOPSY DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • 5.6 ECOSYSTEM MARKET MAP
    • TABLE 16 BREAST BIOPSY DEVICES MARKET: ROLE IN ECOSYSTEM
  • 5.7 TECHNOLOGY ANALYSIS
  • 5.8 TRADE ANALYSIS
    • TABLE 17 IMPORT DATA FOR BIOPSY NEEDLES (HS CODE 90183240), BY COUNTRY, 2018-2022 (USD THOUSAND)
    • TABLE 18 EXPORT DATA FOR BREAST BIOPSY DEVICES (HS CODE 90183240), BY COUNTRY, 2018-2022 (USD THOUSAND)
    • TABLE 19 IMPORT DATA FOR MAMMOGRAPHY DEVICES (HS CODE 90221411), BY COUNTRY, 2018-2022 (USD THOUSAND)
    • TABLE 20 EXPORT DATA FOR MAMMOGRAPHY DEVICES (HS CODE 90221411), BY COUNTRY, 2018-2022 (USD THOUSAND)
  • 5.9 PATENT ANALYSIS
    • FIGURE 25 PATENT DETAILS FOR BREAST BIOPSY (JANUARY 2012-JULY 2023)
  • 5.10 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 21 BREAST BIOPSY DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.10.1 THREAT OF NEW ENTRANTS
    • 5.10.2 THREAT OF SUBSTITUTES
    • 5.10.3 BARGAINING POWER OF SUPPLIERS
    • 5.10.4 BARGAINING POWER OF BUYERS
    • 5.10.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.11 PRICING ANALYSIS
    • 5.11.1 AVERAGE SELLING PRICE OF PRODUCTS, BY TYPE
    • TABLE 22 AVERAGE SELLING PRICE OF PRODUCTS (USD), 2022
    • 5.11.2 AVERAGE SELLING PRICE TRENDS
  • 5.12 CASE STUDY ANALYSIS
    • 5.12.1 CASE STUDY 1: EVOLUTION OF WIRE LOCALIZATION TECHNIQUE
    • FIGURE 26 BREAST TUMOR LOCALIZATION: TECHNOLOGY EVOLUTION CHART
    • 5.12.2 CASE STUDY 2: GROWING BREAST CARE FACILITIES IN US
  • 5.13 KEY CONFERENCES & EVENTS, 2023-2025
    • TABLE 23 BREAST BIOPSY DEVICES MARKET: LIST OF MAJOR CONFERENCES & EVENTS (2023-2025)
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS & BUYING CRITERIA
    • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BREAST BIOPSY DEVICES
    • 5.14.2 BUYING CRITERIA
    • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BREAST BIOPSY DEVICES
    • FIGURE 28 KEY BUYING CRITERIA FOR BREAST BIOPSY DEVICES
    • TABLE 25 KEY BUYING CRITERIA FOR BREAST BIOPSY DEVICES

6 BREAST BIOPSY DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 26 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 27 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2 BIOPSY NEEDLES
    • 6.2.1 TECHNOLOGICAL ADVANCEMENTS IN BIOPSY NEEDLES TO DRIVE MARKET GROWTH
    • TABLE 28 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 29 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 30 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 31 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 32 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY END USER, 2021-2028 (USD MILLION)
  • 6.3 GUIDANCE SYSTEMS
    • 6.3.1 PROCEDURAL ADVANTAGES OF GUIDED BIOPSIES TO FUEL GROWTH
    • TABLE 33 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 34 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 35 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 36 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 37 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY END USER, 2021-2028 (USD MILLION)
  • 6.4 BIOPSY TABLES
    • 6.4.1 GROWING USE OF BIOPSY TABLES TO PERFORM STEREOTACTIC BIOPSY PROCEDURES TO FAVOR MARKET GROWTH
    • TABLE 38 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 39 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 40 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 41 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 42 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY END USER, 2021-2028 (USD MILLION)
  • 6.5 ASSAY KITS
    • 6.5.1 PRODUCT APPROVALS AND LAUNCHES TO DRIVE SEGMENTAL GROWTH
    • TABLE 43 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 44 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 45 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 46 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 47 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY END USER, 2021-2028 (USD MILLION)
  • 6.6 LIQUID BIOPSY INSTRUMENTS
    • 6.6.1 ONGOING RESEARCH AND CLINICAL TRIALS TO DELIVER NOVEL SOLUTIONS IN MARKET
    • TABLE 48 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 49 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 50 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 51 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 52 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY END USER, 2021-2028 (USD MILLION)
  • 6.7 LOCALIZATION WIRES
    • 6.7.1 WIDE USAGE OF LOCALIZATION WIRES TO LOCATE BREAST ABNORMALITIES AND LUMPS TO BOOST MARKET
    • TABLE 53 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 54 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 55 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 56 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 57 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY END USER, 2021-2028 (USD MILLION)
  • 6.8 OTHER DEVICES
    • TABLE 58 OTHER BREAST BIOPSY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 59 OTHER BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 60 OTHER BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 61 OTHER BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 62 OTHER BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)

7 BREAST BIOPSY DEVICES MARKET, BY PROCEDURE

  • 7.1 INTRODUCTION
    • TABLE 63 BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021-2028 (USD MILLION)
  • 7.2 NEEDLE BREAST BIOPSY
    • TABLE 64 BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • 7.2.1 CORE-NEEDLE BIOPSY
      • 7.2.1.1 Procedural advantages of guidance system-based biopsy to drive revenue growth
    • TABLE 65 BREAST BIOPSY DEVICES MARKET FOR CORE-NEEDLE BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 7.2.2 VACUUM-ASSISTED BIOPSY
      • 7.2.2.1 High diagnostic specificity and accuracy of technique to boost demand
    • TABLE 66 BREAST BIOPSY DEVICES MARKET FOR VACUUM-ASSISTED BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 7.2.3 FINE-NEEDLE ASPIRATION BIOPSY
      • 7.2.3.1 Drawbacks associated with procedure to limit market growth
    • TABLE 67 BREAST BIOPSY DEVICES MARKET FOR FINE-NEEDLE ASPIRATION BIOPSY, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 OPEN SURGICAL BREAST BIOPSY
    • TABLE 68 BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • 7.3.1 EXCISIONAL BIOPSY
      • 7.3.1.1 Risk of postoperative complications to hinder market growth
    • TABLE 69 BREAST BIOPSY DEVICES MARKET FOR EXCISIONAL BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 7.3.2 INCISIONAL BIOPSY
      • 7.3.2.1 Longer recovery period associated with incisional biopsy to restrict growth
    • TABLE 70 BREAST BIOPSY DEVICES MARKET FOR INCISIONAL BIOPSY, BY REGION, 2021-2028 (USD MILLION)
  • 7.4 LIQUID BREAST BIOPSY
    • TABLE 71 BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • 7.4.1 CIRCULATING TUMOR CELLS
      • 7.4.1.1 Ability to provide important information on molecular properties of breast tumors to boost market
    • TABLE 72 BREAST BIOPSY DEVICES MARKET FOR CIRCULATING TUMOR CELLS, BY REGION, 2021-2028 (USD MILLION)
    • 7.4.2 CIRCULATING TUMOR DNA
      • 7.4.2.1 Low concentrations of ctDNA to pose challenges in screening mutations
    • TABLE 73 BREAST BIOPSY DEVICES MARKET FOR CIRCULATING TUMOR DNA, BY REGION, 2021-2028 (USD MILLION)
    • 7.4.3 OTHER BIOMARKERS
    • TABLE 74 BREAST BIOPSY DEVICES MARKET FOR OTHER BIOMARKERS, BY REGION, 2021-2028 (USD MILLION)

8 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE

  • 8.1 INTRODUCTION
    • TABLE 75 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
  • 8.2 IMAGE-GUIDED BIOPSY
    • TABLE 76 BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • 8.2.1 MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY
      • 8.2.1.1 Increasing number of government-initiated breast screening programs to drive segmental growth
    • TABLE 77 BREAST BIOPSY DEVICES MARKET FOR MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.2 ULTRASOUND-GUIDED BIOPSY
      • 8.2.2.1 Advantages of technique to boost adoption in coming years
    • TABLE 78 BREAST BIOPSY DEVICES MARKET FOR ULTRASOUND-GUIDED BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.3 MRI-GUIDED BIOPSY
      • 8.2.3.1 High cost and low specificity to affect demand
    • TABLE 79 BREAST BIOPSY DEVICES MARKET FOR MRI-GUIDED BIOPSY, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 LIQUID BIOPSY
    • TABLE 80 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • 8.3.1 PCR-BASED BIOPSY
      • 8.3.1.1 Continuous advancements in PCR technology to propel growth
    • TABLE 81 BREAST BIOPSY DEVICES MARKET FOR PCR-BASED BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.2 NGS-BASED BIOPSY
      • 8.3.2.1 Technological advancements and advantages to drive growth
    • TABLE 82 NGS-BASED TECHNOLOGIES FOR ONCOLOGY APPLICATIONS
    • TABLE 83 BREAST BIOPSY DEVICES MARKET FOR NGS-BASED BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.3 MICROARRAY-BASED BIOPSY
      • 8.3.3.1 Ongoing research and promising results to drive market growth
    • TABLE 84 BREAST BIOPSY DEVICES MARKET FOR MICROARRAY-BASED BIOPSY, BY REGION, 2021-2028 (USD MILLION)
  • 8.4 OTHER TECHNIQUES
    • TABLE 85 BREAST BIOPSY DEVICES MARKET FOR OTHER TECHNIQUES, BY REGION, 2021-2028 (USD MILLION)

9 BREAST BIOPSY DEVICES MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 86 BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 9.2 EARLY CANCER SCREENING
    • 9.2.1 GROWING AWARENESS ABOUT EARLY CANCER DETECTION TO DRIVE MARKET GROWTH
    • TABLE 87 BREAST BIOPSY DEVICES MARKET FOR EARLY CANCER SCREENING, BY REGION, 2021-2028 (USD MILLION)
  • 9.3 THERAPY SELECTION
    • 9.3.1 EMERGENCE OF PLASMA-BASED GENOTYPING TO DRIVE GROWTH IN DEVELOPED COUNTRIES
    • TABLE 88 BREAST BIOPSY DEVICES MARKET FOR THERAPY SELECTION, BY REGION, 2021-2028 (USD MILLION)
  • 9.4 TREATMENT MONITORING
    • 9.4.1 GROWING DEMAND FOR LIQUID BIOPSY FOR REAL-TIME TREATMENT MONITORING TO BOOST MARKET
    • TABLE 89 BREAST BIOPSY DEVICES MARKET FOR TREATMENT MONITORING, BY REGION, 2021-2028 (USD MILLION)
  • 9.5 RECURRENCE MONITORING
    • 9.5.1 UNMET CLINICAL NEEDS TO CREATE OPPORTUNITIES FOR PLAYERS
    • TABLE 90 BREAST BIOPSY DEVICES MARKET FOR RECURRENCE MONITORING, BY REGION, 2021-2028 (USD MILLION)

10 BREAST BIOPSY DEVICES MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 91 BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2 HOSPITALS & SURGICAL CENTERS
    • 10.2.1 RISING DEMAND FOR QUICK AND ACCURATE DIAGNOSIS TO BOOST MARKET
    • TABLE 92 BREAST BIOPSY DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 10.3 BREAST CARE CENTERS
    • 10.3.1 GROWING POPULARITY OF BREAST CARE CENTERS IN DEVELOPED COUNTRIES TO FUEL GROWTH
    • TABLE 93 BREAST BIOPSY DEVICES MARKET FOR BREAST CARE CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 10.4 IMAGING CLINICS & DIAGNOSTIC CENTERS
    • 10.4.1 RISING NUMBER OF PRIVATE IMAGING CENTERS TO CONTRIBUTE TO MARKET GROWTH
    • TABLE 94 BREAST BIOPSY DEVICES MARKET FOR IMAGING CLINICS & DIAGNOSTIC CENTERS, BY REGION, 2021-2028 (USD MILLION)

11 BREAST BIOPSY DEVICES MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 95 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 29 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET SNAPSHOT
    • 11.2.1 NORTH AMERICA: RECESSION IMPACT
    • TABLE 96 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 98 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021-2028 (USD MILLION)
    • TABLE 99 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 100 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 101 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 102 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 103 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 104 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 105 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.2 US
      • 11.2.2.1 US to dominate North American breast biopsy devices market during forecast period
    • TABLE 107 US: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.2.3 CANADA
      • 11.2.3.1 Growing incidence of breast cancer and favorable government guidelines to support market growth
    • TABLE 108 CANADA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 11.3 EUROPE
    • 11.3.1 EUROPE: RECESSION IMPACT
    • TABLE 109 EUROPE: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 110 EUROPE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 111 EUROPE: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021-2028 (USD MILLION)
    • TABLE 112 EUROPE: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 113 EUROPE: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 114 EUROPE: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 115 EUROPE: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 116 EUROPE: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 117 EUROPE: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 118 EUROPE: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 EUROPE: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.2 GERMANY
      • 11.3.2.1 Favorable changes in reimbursement scenario to fuel adoption of technologically advanced products
    • TABLE 120 GERMANY: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.3.3 UK
      • 11.3.3.1 Initiatives by public & private organizations to increase awareness about breast cancer
    • TABLE 121 UK: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.3.4 FRANCE
      • 11.3.4.1 Rising geriatric population to support market growth
    • TABLE 122 FRANCE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.3.5 ITALY
      • 11.3.5.1 Evolving regulatory scenario for breast biopsy to boost market
    • TABLE 123 ITALY: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.3.6 SPAIN
      • 11.3.6.1 Government focus on early and effective breast cancer diagnosis to favor market growth
    • TABLE 124 SPAIN: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.3.7 REST OF EUROPE
    • TABLE 125 REST OF EUROPE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • FIGURE 30 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET SNAPSHOT
    • 11.4.1 ASIA PACIFIC: RECESSION IMPACT
    • TABLE 126 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 128 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021-2028 (USD MILLION)
    • TABLE 129 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 130 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 131 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 133 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 134 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 135 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 136 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.2 CHINA
      • 11.4.2.1 Increasing patient pool and government initiatives for healthcare development to fuel market growth
    • TABLE 137 CHINA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.4.3 JAPAN
      • 11.4.3.1 Presence of universal healthcare reimbursement scenario to support growth
    • TABLE 138 JAPAN: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.4.4 INDIA
      • 11.4.4.1 Government initiatives to improve female health to drive market growth in India
    • TABLE 139 INDIA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 Rising research investments and awareness campaigns to fuel growth
    • TABLE 140 AUSTRALIA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.4.6 SOUTH KOREA
      • 11.4.6.1 Rising R&D and promising clinical trials to positively impact market growth
    • TABLE 141 SOUTH KOREA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.4.7 REST OF ASIA PACIFIC
    • TABLE 142 REST OF ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 11.5 LATIN AMERICA
    • 11.5.1 LATIN AMERICA: RECESSION IMPACT
    • TABLE 143 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 144 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 145 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021-2028 (USD MILLION)
    • TABLE 146 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 147 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 148 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 149 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 150 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 151 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 152 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 153 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.5.2 BRAZIL
      • 11.5.2.1 Brazil to dominate Latin American market during forecast period
    • TABLE 154 BRAZIL: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.5.3 MEXICO
      • 11.5.3.1 Availability of advanced care and increasing awareness programs to fuel market growth
    • TABLE 155 MEXICO: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.5.4 REST OF LATIN AMERICA
    • TABLE 156 REST OF LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.5.5 MIDDLE EAST & AFRICA
      • 11.5.5.1 Improving healthcare infrastructure and increasing public-private investments to drive market
    • 11.5.6 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 157 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 158 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021-2028 (USD MILLION)
    • TABLE 159 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 162 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 163 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 164 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 165 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 166 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
    • FIGURE 31 KEY DEVELOPMENTS BY LEADING PLAYERS IN BREAST BIOPSY DEVICES MARKET, JANUARY 2020-FEBRUARY 2022
  • 12.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • 12.3 REVENUE SHARE ANALYSIS
    • FIGURE 32 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS
  • 12.4 MARKET SHARE ANALYSIS
    • FIGURE 33 BREAST BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER (2022)
  • 12.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • FIGURE 34 BREAST BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (2022)
  • 12.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • FIGURE 35 BREAST BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
  • 12.7 COMPETITIVE BENCHMARKING
    • TABLE 167 BREAST BIOPSY DEVICES MARKET: COMPETITIVE BENCHMARKING
  • 12.8 COMPANY FOOTPRINT ANALYSIS
    • TABLE 168 BREAST BIOPSY DEVICES MARKET: REGIONAL FOOTPRINT ANALYSIS
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES & APPROVALS
    • 12.9.2 DEALS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 13.1.1 HOLOGIC, INC.
    • TABLE 169 HOLOGIC, INC.: BUSINESS OVERVIEW
    • FIGURE 36 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
    • TABLE 170 HOLOGIC, INC.: PRODUCT LAUNCHES & APPROVALS
    • TABLE 171 HOLOGIC, INC.: DEALS
    • 13.1.2 DANAHER CORPORATION
    • TABLE 172 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 173 DANAHER CORPORATION: PRODUCT LAUNCHES
    • 13.1.3 BECTON, DICKINSON AND COMPANY
    • TABLE 174 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
    • TABLE 175 BECTON, DICKINSON AND COMPANY: EXPANSIONS
    • 13.1.4 QIAGEN
    • TABLE 176 QIAGEN: BUSINESS OVERVIEW
    • FIGURE 39 QIAGEN: COMPANY SNAPSHOT (2022)
    • TABLE 177 QIAGEN: PRODUCT LAUNCHES
    • 13.1.5 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 178 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
    • FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
    • 13.1.6 ARGON MEDICAL DEVICES
    • TABLE 179 ARGON MEDICAL DEVICES: BUSINESS OVERVIEW
    • TABLE 180 ARGON MEDICAL DEVICES: PRODUCT LAUNCHES
    • TABLE 181 ARGON MEDICAL DEVICES: DEALS
    • 13.1.7 MERIT MEDICAL SYSTEMS
    • TABLE 182 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
    • FIGURE 41 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2022)
    • TABLE 183 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS
    • TABLE 184 MERIT MEDICAL SYSTEMS: DEALS
    • 13.1.8 MENARINI SILICON BIOSYSTEMS SPA
    • TABLE 185 MENARINI SILICON BIOSYSTEMS: BUSINESS OVERVIEW
    • TABLE 186 MENARINI SILICON BIOSYSTEMS: PRODUCT LAUNCHES
    • TABLE 187 MENARINI SILICON BIOSYSTEMS: DEALS
    • 13.1.9 GUARDANT HEALTH, INC.
    • TABLE 188 GUARDANT HEALTH, INC.: BUSINESS OVERVIEW
    • FIGURE 42 GUARDANT HEALTH, INC.: COMPANY SNAPSHOT (2022)
    • TABLE 189 GUARDANT HEALTH, INC.: DEALS
    • 13.1.10 NEOGENOMICS LABORATORIES, INC.
    • TABLE 190 NEOGENOMICS LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 43 NEOGENOMICS LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • TABLE 191 NEOGENOMICS LABORATORIES, INC.: PRODUCT LAUNCHES
    • TABLE 192 NEOGENOMICS LABORATORIES, INC.: DEALS
    • 13.1.11 STERYLAB S.R.L
    • TABLE 193 STERYLAB S.R.L: BUSINESS OVERVIEW
    • 13.1.12 BIOCEPT, INC.
    • TABLE 194 BIOCEPT, INC.: BUSINESS OVERVIEW
    • 13.1.13 BIO-RAD LABORATORIES, INC.
    • TABLE 195 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • 13.1.14 EXACT SCIENCES CORPORATION
    • TABLE 196 EXACT SCIENCES CORPORATION: BUSINESS OVERVIEW
    • FIGURE 45 EXACT SCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 197 EXACT SCIENCES CORPORATION: DEALS
    • 13.1.15 SYSMEX INOSTICS, INC. (A SUBSIDIARY OF SYSMEX CORPORATION)
    • TABLE 198 SYSMEX INOSTICS: BUSINESS OVERVIEW
    • FIGURE 46 SYSMEX INOSTICS: COMPANY SNAPSHOT (2022)
    • TABLE 199 SYSMEX INOSTICS: DEALS
  • 13.2 OTHER PLAYERS
    • 13.2.1 THERMO FISHER SCIENTIFIC
    • 13.2.2 CARDIFF ONCOLOGY INC.
    • 13.2.3 MYRIAD GENETICS, INC.
    • 13.2.4 ILLUMINA, INC.
    • 13.2.5 FLUXION BIOSCIENCES, INC.
    • 13.2.6 FUJIFILM HOLDINGS CORPORATION
    • 13.2.7 INRAD, INC.
    • 13.2.8 IZI MEDICAL PRODUCTS
    • 13.2.9 REMINGTON MEDICAL INC.
    • 13.2.10 CP MEDICAL
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS